γ-Interferon enhances expression of CD14/MyD88 and subsequent responsiveness to lipopolysaccharide from Actinobacillus actinomycetemcomitans in human gingival fibroblasts

Journal of Periodontal Research

Volumn 39, Issue 5, 2004, Pages 333-343

  Mochizuki, S ^a   Kobayashi, M ^a   Suzuki, T ^a   Oikawa, A ^a   Koseki, T ^b   Nishihara, T ^c   Hasegawa, K ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Kyushu Dental Collage ^*  (Japan)

Author keywords

interferon; CD14 toll like receptor 4 Myd88; Human gingival fibroblasts; Lipopolysaccharide responsiveness

Indexed keywords

ANTIBODY; CD14 ANTIGEN; HTA 125; I KAPPA B ALPHA; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; MY 4; MYELOID DIFFERENTIATION FACTOR 88; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; GINGIVA; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; HUMANS; I-KAPPA B KINASE; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 4644226057     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00749.x     Document Type: Article

References (54)

1. Hanazawa S, Kawata Y, Takeshita A et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: Increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993;61:5219-5224.
2. Takada H, Mihara J, Morisaki I, Hamada S. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun 1991;59:295-301.
3. Tamura M, Tokuda M, Nagaoka S, Takada H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun 1992;60:4932-4937.
4. Agarwal S, Baran C, Piesco NP et al. Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1β. J Periodont Res 1995;30:382-389.
5. Imatani T, Kato T, Okuda K. Production of inflammatory cytokines by human gingival fibroblasts stimulated by cell-surface preparations of Porphyromonas gingivalis. Oral Microbiol Immunol 2001;16:65-72.
6. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-457.
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and lipopolysaccharide binding protein. Science 1990;249:1431-1433.
8. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121-125.
9. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidy-linositol linkage. J Immunol 1988;141:547-552.
10. Bazil V, Horejsi V, Baudys M et al. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 1986;16:1583-1589.
11. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-787.
12. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999;11:13-18.
13. Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000;11:219-232.
14. Wright SD. Toll, A new piece in the puzzle of innate immunity. J Exp Med 1999;189:605-609.
15. Poltorak A, He X, Smirnova I et al. Defective lipopolysaccharide signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
16. Qureshi ST, Lariviere L, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999;189:615-625.
17. n gene: in vivo evidence for a dominant negative mutation. J Immunol 1999;162:5666-5670.
18. Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
19. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-191.
20. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Esherichia and Salmonella lipopolysaccharides. J Immunol 2000;165:5780-5787.
21. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000;12:113-117.
22. Wang PL, Sato K, Oido M et al. Involvement of CD14 on human gingival fibroblasts in Porphyromonas gingivalis lipopolysaccharide-mediated interleukin-6 secretion. Arch Oral Biol 1998;43:687-694.
23. Hiraoka T, Izumi Y, Sueda T. Immunochemical detection of CD14 on human gingival fibroblasts in vitro. Oral Microbiol Immunol 1998;13:246-252.
24. Sugawara S, Sugiyama A, Nemoto E, Rikiishi H, Takada H. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun 1998;66:3043-3049.
25. Nemoto E, Sugawara S, Tada H, Takada H, Shimauchi H, Horiuchi H. Cleavage of CD14 on human gingival fibroblasts cocultured with activated neutrophils is mediated by human leukocyte elastase resulting in down-regulation of lipopolysaccharide-induced interleukin-8 production. J Immunol 2000;165:5807-5813.
26. Watanabe A, Takeshita A, Kitano S, Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 1996;64:4488-4494.
27. Tabeta K. Yamazaki K, Akashi S et al. Toll-like receptor confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 2000;68:3731-3735.
28. Wang PL, Azuma Y, Shinohara M, Ohura K. Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Biochem Biophys Res Commun 2000;273:1161-1167.
29. Modlin RL, Brightbill HD, Godowski PJ. The toll of innate immunity on microbial pathogens. N Engl J Med 1999;340:1834-1835.
30. Swantek JL, Cobb MH, Geppert TD. Jun N-Terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 1997;17:6274-6282.
31. Hambleton J, Weinstein SL, Lem L, DeFranco AL. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 1996;93:2774-2778.
32. Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-746.
33. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BMJ, Brennan FM. Regulation of monocyte interleukin-10 synthesis by endogenous interleukin-1 and TNF-α. role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 1998;160:920-928.
34. Dean JLE, Brook M, Clark AR, Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999;274:264-269.
35. 2 production in lipopolysaccharide-stimulated monocytes. J Immunol 1998;161:5681-5686.
36. Kotlyarov A, Neininger A, Schubert C et al. MAPKAP kinase 2 is essential for lipopolysaccharide-induced TNF-alpha biosynthesis. Nat Cell Biol 1999;1:94-97.
37. Liu S, Khemlani LS, Shapiro RA et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 1998;66:5089-5098.
38. Fearns C, Loskutoff DJ. Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 1997;65:4822-4831.
39. Fearns C, Ulevitch RJ. Effect of recombinant interleukin-1beta on murine CD14 gene expression in vivo. Shock 1998;9:157-163.
40. d and tumor necrosis factor receptor-deficient mice. Eur J Immunol 1996;26:2686-2692.
41. + fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression. Infect Immun 2002;70:1272-1278.
42. Nishihara T, Koga T, Hamada S. Extra-cellular proteinaceous substances from Haemophilus actinomycetemcomitans induce mitogenic responses in murine lymphocytes. Oral Microbiol Immunol 1987;2:48-52.
43. Westphal O, Jann K. Bacterial lipopolysaccharide. Extraction with phenol-water and further application of the procedure. Meth Carbohydr Chem 1965;5:83-91.
44. Nishihara T, Fujiwara T, Koga T, Hamada S. Chemical composition and immunobiological properties of lipopolysaccharide and lipid-associated proteoglycan from Actinobacillus actinomycetemcomitans. J Periodont Res 1986;21:521-530.
45. Bosisio D, Polentarutti N, Sironi M et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002;99:3427-3431.
46. Kirikae T, Nitta T, Kirikae F et al. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by lipopolysaccharide-refractory C3H/HeJ macrophages in a way different from that of Salmonella lipopolysaccharide. Infect Immun 1999;67:1736-1742.
47. Ogawa T, Nakazawa M, Masui K. Immunopharmacological activities of the nontoxic monophosphoryl lipid A of Porphyromonas gingivalis. Vaccine 1996;14:70-76.
48. Ogawa T, Shimauchi H, Uchida H, Mori Y. Stimulation of splenocytes in C3H/HeJ mice with Porphyromonas gingivalis lipid A in comparison with enterobacterial lipid A. Immunobiology 1996;196:399-414.
49. Shimauchi H, Ogawa T, Uchida H et al. Splenic B-cell activation in lipopolysaccharide-non-responsive C3H/HeJ mice by lipopolysaccharide of Porphyromonas gingivalis. Experientia 1996;52:909-917.
50. Tanamoto K, Azumi S, Haishima Y, Kumada H, Umemoto T. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice. J Immunol 1997;158:4430-4436.
51. Hirschfeld M, Weis JJ, Toshchakov V et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001;69:1477-1482.
52. Yoshimura A, Kaneko T, Kato Y et al. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagov nists for human Toll-like receptor 4. Infect Immun 2002;70:218-225.
53. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999;11:115-122.
54. Kawai T, Takeuchi O, Fujita T et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001;167:5887-5894.